title: Evidence-based or stock market-driven nephrology?
authors.forename: Costas
authors.initials: C
authors.lastname: Fourtounas
mesh_terms: D000740:Anemia / Q000188:drug therapy*; D004345:Drug Industry; D004921:Erythropoietin / Q000627:therapeutic use*; D006397:Hematinics; D006801:Humans; D017410:Practice Guidelines as Topic; D011994:Recombinant Proteins; D006435:Renal Dialysis / Q000009:adverse effects*
chemical_list: D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin